fda bpc 157 category 2 bulk drug substances compounding list Peptide Reclassification 2026: What It Means for Providers Exciting news for peptides coming
Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. FDA advisers back first four of seven unapproved peptides under review for looser rules Reuters Survey: Half of Peptide Users Aren't Aware of FDA Approval Status
Pay in 4 interest-free payments of $6.90 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20

